HbA 1cand cardiovascular risk score identify people who may benefit from preventive interventions: A 7 year follow-up of a high-risk screening programme for diabetes in primary care (ADDITION), Denmark

Diabetologia

Volumn 54, Issue 6, 2011, Pages 1318-1326

  Lauritzen, T ^a   Sandbaek, A ^a   Skriver, M V ^a   Borch Johnsen, K ^a,b,c  

^a AARHUS UNIVERSITY   (Denmark)

^b STENO DIABETES CENTER   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

All cause mortality; Cardiovascular risk; HbA 1c; SCORE; Screening; Type 2 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; GLUCOSE; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DENMARK; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HAZARD RATIO; HEALTH PROGRAM; HUMAN; HUMAN EXPERIMENT; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE MODIFICATION; MALE; MASS SCREENING; MORTALITY; PATIENT IDENTIFICATION; PRIMARY HEALTH CARE; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; BLOOD; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIET RESTRICTION; GLUCOSE TOLERANCE TEST; METABOLISM; METHODOLOGY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADULT; AGED; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DENMARK; DIABETES MELLITUS; FASTING; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PRIMARY HEALTH CARE; RISK ASSESSMENT; RISK FACTORS;

EID: 80052520015     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2077-9     Document Type: Article

References (24)

1. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053 (Pubitemid 38579764)
2. Preis SR, Hwang SJ, Coady S et al (2009) Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation 119:1728-1735
3. Gu K, Cowie CC, Harris MI (1998) Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care 21:1138-1145 (Pubitemid 28368522)
4. American Heart Association (2009) Heart disease and stroke statistics - 2009 update. American Heart Association, Dallas
5. King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414-1431 (Pubitemid 28405191)
6. Glumer C, Jorgensen T, Borch-Johnsen K (2003) Prevalences of diabetes and impaired glucose regulation in a Danish population: the Inter99 Study. Diabetes Care 26:2335-2340 (Pubitemid 36993322)
7. Williams DR, Wareham NJ, Brown DC et al (1995) Undiagnosed glucose intolerance in the community: the Isle of Ely Diabetes Project. Diabet Med 12:30-35
8. Glumer C, Yuyun M, Griffin S et al (2006) What determines the cost-effectiveness of diabetes screening? Diabetologia 49:1536-1544 (Pubitemid 43848089)
9. Kahn R, Robertson RM, Smith R, Eddy D (2008) The impact of prevention on reducing the burden of cardiovascular disease. Circulation 118:576-585
10. International Expert Committee (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32:1327-1334
11. Lauritzen T, Griffin S, Borch JK et al (2000) The ADDITION Study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality amongpeople with type 2 diabetes detected by screening. Int J Obes Relat Metab Disord 24(Suppl 3):S6-S11
12. Glumer C, Carstensen B, Sandbaek A, Lauritzen T, Jorgensen T, Borch-Johnsen K (2004) A Danish diabetes risk score for targeted screening: the Inter99 Study. Diabetes Care 27:727-733 (Pubitemid 38280541)
13. Conroy RM, Pyorala K, Fitzgerald AP et al (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24:987-1003 (Pubitemid 36712275)
14. WHO (1999) Definition, diagnosis and classification of diabetes mellitus and its complications: repot of a WHO Consultation. Part 1 Diagnosis and classification of diabetes mellitus. WHO, Geneva
15. Sandbaek A, Lauritzen T, Borch-Johnsen K (2005) The comparison of venous plasma glucose and whole blood capillary glucose in diagnoses of type 2 diabetes: a population-based screening study. Diabet Med 22:1173-1177 (Pubitemid 41224176)
16. Kahn R, Alperin P, Eddy D et al (2010) Age at initiation and frequency of screening to detect type 2 diabetes: a costeffectiveness analysis. Lancet 375:1365-1374
17. Gaede P, Lund-Andersen H, Parving HH, Pedersen O (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358:580-591 (Pubitemid 351214285)
18. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577-1589
19. Graversen L, Christensen B, Borch-Johnsen K, Lauritzen T, Sandbaek A (2010) General practitioners' adherence to guidelines on management of dyslipidaemia: ADDITION-Denmark. Scand J Prim Health Care 28:47-54
20. O'Connor PJ, Rush WA, Cherney LM, Pronk NP (2001) Screening for diabetes mellitus in high-risk patients: cost, yield, and acceptability. Eff Clin Pract 4:271-277
21. Christensen JO, Sandbaek A, Lauritzen T, Borch-Johnsen K (2004) Population-based stepwise screening for unrecognised type 2 diabetes is ineffective in general practice despite reliable algorithms. Diabetologia 47:1566-1573 (Pubitemid 39371639)
22. Spijkerman AM, Adriaanse MC, Dekker JM et al (2002) Diabetic patients detected by population-based stepwise screening already have a diabetic cardiovascular risk profile. Diabetes Care 25:1784-1789 (Pubitemid 41071087)
23. Sandbaek A, Griffin SJ, Rutten G et al (2008) Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION Study. Diabetologia 51:1127-1134
24. Lauritzen T, Jensen MS, Thomsen JL, Christensen B, Engberg M (2008) Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5-year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scand J Public Health 36:650-661